ADESSO SE (ADN1.DE) Stock Fundamental Analysis
Europe - Frankfurt Stock Exchange - FRA:ADN1 - DE000A0Z23Q5 - Common Stock
87.1 EUR
-1.9 (-2.13%)
Taking everything into account, ADN1 scores 5 out of 10 in our fundamental rating. ADN1 was compared to 76 industry peers in the IT Services industry. ADN1 has an average financial health and profitability rating. ADN1 is not priced too expensively while it is growing strongly. Keep and eye on this one!
1. Profitability
1.1 Basic Checks
- ADN1 had positive earnings in the past year.
- In the past year ADN1 had a positive cash flow from operations.
- Each year in the past 5 years ADN1 has been profitable.
- Each year in the past 5 years ADN1 had a positive operating cash flow.
1.2 Ratios
- Looking at the Return On Assets, with a value of 2.45%, ADN1 is doing worse than 64.47% of the companies in the same industry.
- The Return On Equity of ADN1 (10.90%) is comparable to the rest of the industry.
- The Return On Invested Capital of ADN1 (5.23%) is worse than 65.79% of its industry peers.
- The Average Return On Invested Capital over the past 3 years for ADN1 is significantly below the industry average of 25.98%.
- The last Return On Invested Capital (5.23%) for ADN1 is above the 3 year average (3.16%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.45% | ||
| ROE | 10.9% | ||
| ROIC | 5.23% |
ROA(3y)1.93%
ROA(5y)3.99%
ROE(3y)6.49%
ROE(5y)13.12%
ROIC(3y)3.16%
ROIC(5y)4.51%
1.3 Margins
- Looking at the Profit Margin, with a value of 0.99%, ADN1 is doing worse than 67.11% of the companies in the same industry.
- ADN1's Profit Margin has declined in the last couple of years.
- With a Operating Margin value of 2.96%, ADN1 is not doing good in the industry: 68.42% of the companies in the same industry are doing better.
- ADN1's Operating Margin has declined in the last couple of years.
- With a decent Gross Margin value of 85.30%, ADN1 is doing good in the industry, outperforming 76.32% of the companies in the same industry.
- ADN1's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 2.96% | ||
| PM (TTM) | 0.99% | ||
| GM | 85.3% |
OM growth 3Y-30%
OM growth 5Y-15.03%
PM growth 3Y-55.28%
PM growth 5Y-30.54%
GM growth 3Y-0.02%
GM growth 5Y-0.7%
2. Health
2.1 Basic Checks
- ADN1 has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
- Compared to 1 year ago, ADN1 has less shares outstanding
- Compared to 5 years ago, ADN1 has more shares outstanding
- ADN1 has a better debt/assets ratio than last year.
2.2 Solvency
- ADN1 has an Altman-Z score of 3.63. This indicates that ADN1 is financially healthy and has little risk of bankruptcy at the moment.
- The Altman-Z score of ADN1 (3.63) is better than 75.00% of its industry peers.
- The Debt to FCF ratio of ADN1 is 7.88, which is on the high side as it means it would take ADN1, 7.88 years of fcf income to pay off all of its debts.
- The Debt to FCF ratio of ADN1 (7.88) is worse than 69.74% of its industry peers.
- ADN1 has a Debt/Equity ratio of 1.60. This is a high value indicating a heavy dependency on external financing.
- ADN1's Debt to Equity ratio of 1.60 is on the low side compared to the rest of the industry. ADN1 is outperformed by 78.95% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.6 | ||
| Debt/FCF | 7.88 | ||
| Altman-Z | 3.63 |
ROIC/WACC0.51
WACC10.33%
2.3 Liquidity
- ADN1 has a Current Ratio of 1.30. This is a normal value and indicates that ADN1 is financially healthy and should not expect problems in meeting its short term obligations.
- ADN1 has a Current ratio (1.30) which is comparable to the rest of the industry.
- A Quick Ratio of 1.30 indicates that ADN1 should not have too much problems paying its short term obligations.
- ADN1 has a Quick ratio of 1.30. This is in the better half of the industry: ADN1 outperforms 61.84% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.3 | ||
| Quick Ratio | 1.3 |
3. Growth
3.1 Past
- ADN1 shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 200.98%, which is quite impressive.
- The earnings per share for ADN1 have been decreasing by -15.02% on average. This is quite bad
- The Revenue has grown by 12.60% in the past year. This is quite good.
- The Revenue has been growing by 23.60% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)200.98%
EPS 3Y-45.14%
EPS 5Y-15.02%
EPS Q2Q%9.8%
Revenue 1Y (TTM)12.6%
Revenue growth 3Y24.12%
Revenue growth 5Y23.6%
Sales Q2Q%13.44%
3.2 Future
- The Earnings Per Share is expected to grow by 39.34% on average over the next years. This is a very strong growth
- ADN1 is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 10.28% yearly.
EPS Next Y83.56%
EPS Next 2Y76.08%
EPS Next 3Y63.28%
EPS Next 5Y39.34%
Revenue Next Year10.53%
Revenue Next 2Y10.3%
Revenue Next 3Y10.23%
Revenue Next 5Y10.28%
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
- The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
- Based on the Price/Earnings ratio of 27.30, the valuation of ADN1 can be described as expensive.
- ADN1's Price/Earnings ratio is in line with the industry average.
- ADN1's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 27.38.
- The Price/Forward Earnings ratio is 15.40, which indicates a correct valuation of ADN1.
- ADN1's Price/Forward Earnings ratio is in line with the industry average.
- When comparing the Price/Forward Earnings ratio of ADN1 to the average of the S&P500 Index (24.29), we can say ADN1 is valued slightly cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 27.3 | ||
| Fwd PE | 15.4 |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, ADN1 is valued a bit cheaper than 69.74% of the companies in the same industry.
- Based on the Price/Free Cash Flow ratio, ADN1 is valued a bit cheaper than 64.47% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 12.17 | ||
| EV/EBITDA | 6.63 |
4.3 Compensation for Growth
- ADN1's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
- ADN1's earnings are expected to grow with 63.28% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.33
PEG (5Y)N/A
EPS Next 2Y76.08%
EPS Next 3Y63.28%
5. Dividend
5.1 Amount
- ADN1 has a yearly dividend return of 0.83%, which is pretty low.
- ADN1's Dividend Yield is comparable with the industry average which is at 2.10.
- With a Dividend Yield of 0.83, ADN1 pays less dividend than the S&P500 average, which is at 1.85.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.83% |
5.2 History
- The dividend of ADN1 is nicely growing with an annual growth rate of 15.65%!
Dividend Growth(5Y)15.65%
Div Incr Years5
Div Non Decr Years6
5.3 Sustainability
- ADN1 pays out 31.75% of its income as dividend. This is a sustainable payout ratio.
- ADN1's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP31.75%
EPS Next 2Y76.08%
EPS Next 3Y63.28%
FRA:ADN1 (1/19/2026, 3:37:40 PM)
87.1
-1.9 (-2.13%)
Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)11-12 2025-11-12
Earnings (Next)03-31 2026-03-31/amc
Inst Owners20.34%
Inst Owner ChangeN/A
Ins Owners50.28%
Ins Owner ChangeN/A
Market Cap568.76M
Revenue(TTM)2.10B
Net Income(TTM)20.84M
Analysts83.33
Price Target130.39 (49.7%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.83% |
Yearly Dividend0.94
Dividend Growth(5Y)15.65%
DP31.75%
Div Incr Years5
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)2.97%
PT rev (3m)2.03%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-10.38%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.07%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 27.3 | ||
| Fwd PE | 15.4 | ||
| P/S | 0.27 | ||
| P/FCF | 12.17 | ||
| P/OCF | 7.32 | ||
| P/B | 2.98 | ||
| P/tB | 11.23 | ||
| EV/EBITDA | 6.63 |
EPS(TTM)3.19
EY3.66%
EPS(NY)5.65
Fwd EY6.49%
FCF(TTM)7.16
FCFY8.22%
OCF(TTM)11.9
OCFY13.66%
SpS322.11
BVpS29.27
TBVpS7.75
PEG (NY)0.33
PEG (5Y)N/A
Graham Number45.84
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.45% | ||
| ROE | 10.9% | ||
| ROCE | 11.91% | ||
| ROIC | 5.23% | ||
| ROICexc | 5.78% | ||
| ROICexgc | 8.22% | ||
| OM | 2.96% | ||
| PM (TTM) | 0.99% | ||
| GM | 85.3% | ||
| FCFM | 2.22% |
ROA(3y)1.93%
ROA(5y)3.99%
ROE(3y)6.49%
ROE(5y)13.12%
ROIC(3y)3.16%
ROIC(5y)4.51%
ROICexc(3y)4.06%
ROICexc(5y)6.01%
ROICexgc(3y)6.65%
ROICexgc(5y)10.11%
ROCE(3y)7.2%
ROCE(5y)10.26%
ROICexgc growth 3Y-20.34%
ROICexgc growth 5Y-12.01%
ROICexc growth 3Y-21.84%
ROICexc growth 5Y-11.01%
OM growth 3Y-30%
OM growth 5Y-15.03%
PM growth 3Y-55.28%
PM growth 5Y-30.54%
GM growth 3Y-0.02%
GM growth 5Y-0.7%
F-Score7
Asset Turnover2.47
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.6 | ||
| Debt/FCF | 7.88 | ||
| Debt/EBITDA | 2.26 | ||
| Cap/Depr | 42.37% | ||
| Cap/Sales | 1.47% | ||
| Interest Coverage | 5.03 | ||
| Cash Conversion | 57.42% | ||
| Profit Quality | 224.33% | ||
| Current Ratio | 1.3 | ||
| Quick Ratio | 1.3 | ||
| Altman-Z | 3.63 |
F-Score7
WACC10.33%
ROIC/WACC0.51
Cap/Depr(3y)52.06%
Cap/Depr(5y)49.68%
Cap/Sales(3y)2.64%
Cap/Sales(5y)2.54%
Profit Quality(3y)790.41%
Profit Quality(5y)538.39%
High Growth Momentum
Growth
EPS 1Y (TTM)200.98%
EPS 3Y-45.14%
EPS 5Y-15.02%
EPS Q2Q%9.8%
EPS Next Y83.56%
EPS Next 2Y76.08%
EPS Next 3Y63.28%
EPS Next 5Y39.34%
Revenue 1Y (TTM)12.6%
Revenue growth 3Y24.12%
Revenue growth 5Y23.6%
Sales Q2Q%13.44%
Revenue Next Year10.53%
Revenue Next 2Y10.3%
Revenue Next 3Y10.23%
Revenue Next 5Y10.28%
EBIT growth 1Y38.36%
EBIT growth 3Y-13.12%
EBIT growth 5Y5.01%
EBIT Next Year304.77%
EBIT Next 3Y78.82%
EBIT Next 5Y44.13%
FCF growth 1Y300.77%
FCF growth 3Y40.19%
FCF growth 5Y49.54%
OCF growth 1Y1010.67%
OCF growth 3Y32.14%
OCF growth 5Y37.69%
ADESSO SE / ADN1.DE FAQ
What is the ChartMill fundamental rating of ADESSO SE (ADN1.DE) stock?
ChartMill assigns a fundamental rating of 5 / 10 to ADN1.DE.
Can you provide the valuation status for ADESSO SE?
ChartMill assigns a valuation rating of 5 / 10 to ADESSO SE (ADN1.DE). This can be considered as Fairly Valued.
What is the profitability of ADN1 stock?
ADESSO SE (ADN1.DE) has a profitability rating of 4 / 10.
What are the PE and PB ratios of ADESSO SE (ADN1.DE) stock?
The Price/Earnings (PE) ratio for ADESSO SE (ADN1.DE) is 27.3 and the Price/Book (PB) ratio is 2.98.
Can you provide the expected EPS growth for ADN1 stock?
The Earnings per Share (EPS) of ADESSO SE (ADN1.DE) is expected to grow by 83.56% in the next year.